NiKang Therapeutics has concluded the first cohort dosing in the open-label Phase I trial of NKT3964 as a monotherapy for ...

New research from an international team of plant biologists, led by researchers at the VIB-UGent Center for Plant Systems Biology, has revealed crucial insights into the role brassinosteroids – ...

Matthew Matasar, MD, discussed what the findings from the ELM-1 trial of odronextamab in diffuse large B-cell lymphoma mean ...

The intrinsic factor of cell senescence, PCBP2, was identified by unlabeled quantitative proteomics, and its biological role in in vitro replication senescence of human bone marrow mesenchymal stromal ...

Learn how sleep timing impacts longevity, metabolism, brain health, and overall wellbeing with simple schedule adjustments.

High levels of ammonia kill liver cells by damaging the mitochondria that power the cells. But this can be prevented using an ...

Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Good morning, ladies and gentlemen, and thank you for standing by.

The United States Cutaneous Lymphoma Consortium is a multidisciplinary society of physicians which use collaborative research and education to improve the quality of life and prognosis of patients ...

Scientists have uncovered how ammonia wreaks havoc on liver cells by damaging mitochondria, leading to a dangerous cycle of toxicity. This discovery provides new hope as an existing drug, YAQ-005, ...

Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in ...

The FDA has accepted the resubmission of a BLA for odronextamab for the treatment of patients with relapsed/refractory ...